
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1019 | 1019 | 1000 | 1152 | 1712 | 1504 |
Fund Return | 1.86% | 1.86% | -0.02% | 4.84% | 11.35% | 4.16% |
Place in category | 1752 | 1752 | 1715 | 1272 | 927 | 590 |
% in Category | 84 | 84 | 84 | 72 | 63 | 61 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global SmartBeta Equity ZI Capitale | 1.86B | -3.80 | 8.24 | 9.56 | ||
LU1774149998 | 1.86B | -3.88 | 7.86 | 9.17 | ||
LU1536921650 | 752.68M | -14.97 | -0.45 | - | ||
Global Optimal Income A Capitalisat | 557.5M | -3.87 | 0.48 | 1.54 | ||
Global Optimal Income E Capitalisat | 557.5M | -3.99 | -0.02 | 1.04 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund Y Acc EUR | 188.99M | 4.21 | 9.89 | 5.11 | ||
European Growth Fund Y DIST EUR | 61.21M | 4.24 | 9.91 | 5.11 | ||
European Growth Fund A DIST Eue | 6.19B | 4.01 | 8.97 | 4.24 | ||
European Growth Fund A Acc EUR | 156.8M | 4.00 | 8.97 | 4.24 | ||
European Growth Fund E Acc EUR | 21.18M | 3.80 | 8.15 | 3.46 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ASML Holding | NL0010273215 | 5.55 | 577.30 | -0.05% | |
AstraZeneca | GB0009895292 | 4.79 | 10,008.0 | -0.10% | |
Allianz | DE0008404005 | 4.47 | 328.00 | -0.30% | |
Saint Gobain | FR0000125007 | 2.95 | 82.36 | +0.51% | |
Ashtead Group | GB0000536739 | 2.91 | 3,819.0 | -1.29% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review